+
  • 图片 5.png

Moxifloxacin hydrochloride


186826-86-8

Standardized and sophisticated testing instruments and a high-quality workforce have created a large domestic production base of gatifloxacin; the technical advantages and production scale of perindopril tert-butylamine salt intermediate indoline-2-carboxylic acid series products are also among the best at home and abroad, with a good reputation.


Product Details


Product Name: Moxifloxacin Hydrochloride
Chemical name: 1-cyclopropyl -7-(S,S-2,8-diazo-bicyclo [4.3.0] nonan-8-yl)-6-fluoro -8-methoxy-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride
Cas No.:186826-86-8
Structural formula:

Technical indicators:

Project Standard
Traits light yellow or yellow crystalline powder, slightly hygroscopic.
Solubility Soluble in water, slightly soluble in 96% ethanol, practically insoluble in acetone.
Identification A) specific rotation:-125 ° to -138 °
B) IR: consistent with the reference spectrum.
C) Chloride identification reaction in aqueous solution.
PH 3.9 to 4.6
Related substances Impurity A, Impurity B, Impurity, Impurity D, Impurity E ≤. 0.1 Unknown Impurity ≤. 0.1 Total Impurity ≤. 0.3%
isomers ≤. 0.1%
Moisture (K.F) ≤. 4.5%
Residue ≤. 0.1%
Content (HPLC) More than 99.0% based on anhydrous substance

 

Standardized and sophisticated testing instruments and a high-quality workforce have created a large domestic production base of gatifloxacin; the technical advantages and production scale of perindopril tert-butylamine salt intermediate indoline-2-carboxylic acid series products are also among the best at home and abroad, with a good reputation. Four of these APIs have passed the national GMP certification, and two other APIs are under approval. The company has two major advantages of reaction: 1. high pressure hydrogenation reaction; 2. enzyme catalytic reaction.


Related Products


Message consultation